Application no. and date | 14778339.3 (espacenet) (Federated) (European Patent Register), 20140403 | Patent/reg. no. and date | DK/EP 2981258, 20200812 | Publication date | 20160210 | Priority no. and date | US 201361808962 P, 20130405 | EP pub. no. and date |
EP 2981258 20160210 | Effective date | | Applicant/owner | scPharmaceuticals Inc., 2400 District Avenue, Suite 310
Burlington, MA 01803, US | Applicant ref. no. | V2009-093-DK | Inventor | MUNTENDAM, Pieter, c/o scPharmaceuticals LLC 75 Arlington Street Boston, Massachusetts 02116, US, MICHAELS, Scott, A., c/o scPharmaceuticals LLC 75 Arlington Street
Boston, Massachusetts 02116, US, LARSEN, Glenn, R., c/o scPharmaceuticals LLC 75 Arlington Street
Boston, Massachusetts 02116, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/341 (2006.01) , A61K 31/635 (2006.01) , A61K 47/02 (2006.01) , A61K 47/18 (2017.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 9/04 (2006.01) , A61P 9/12 (2006.01) | Title | FARMACEUTISKE FORMULERINGER TIL SUBKUTAN INDGIVELSE AF FUROSEMID | Int. application no. | US2014032800 | Int. publication no. | WO2014165660 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|